- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
STAT3 pathway as a molecular target for resveratrol in breast cancer treatment ; volume:21 ; number:1 ; day:6 ; month:9 ; year:2021 ; pages:1-9 ; date:12.2021
Cancer cell international ; 21, Heft 1 (6.9.2021), 1-9, 12.2021
- Creator
-
Kohandel, Zeynab
Farkhondeh, Tahereh
Aschner, Michael
Pourbagher-Shahri, Ali Mohammad
Samarghandian, Saeed
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-02179-1
- URN
-
urn:nbn:de:101:1-2021111820572338889963
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kohandel, Zeynab
- Farkhondeh, Tahereh
- Aschner, Michael
- Pourbagher-Shahri, Ali Mohammad
- Samarghandian, Saeed
- SpringerLink (Online service)
Other Objects (12)
Role of STAT3 signaling pathway in breast cancer
Resveratrol protects human nucleus pulposus cells from degeneration by blocking IL-6/JAK/STAT3 pathway
STAT3: Key targets of growth-promoting receptor positive breast cancer
Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells
Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway
Advancement of Wnt signal pathway and the target of breast cancer
Role of STAT3 signaling pathway in breast cancer
Resveratrol protects human nucleus pulposus cells from degeneration by blocking IL-6/JAK/STAT3 pathway
STAT3: Key targets of growth-promoting receptor positive breast cancer
Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells
Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway
Advancement of Wnt signal pathway and the target of breast cancer
Role of STAT3 signaling pathway in breast cancer
Resveratrol protects human nucleus pulposus cells from degeneration by blocking IL-6/JAK/STAT3 pathway
STAT3: Key targets of growth-promoting receptor positive breast cancer
Resveratrol ameliorates glioblastoma inflammatory response by reducing NLRP3 inflammasome activation through inhibition of the JAK2/STAT3 pathway
ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway
STAT3 as a potential therapeutic target in triple negative breast cancer: a systematic review
Inhibition of STAT3 signaling as critical molecular event in resveratrol-suppressed ovarian cancer cells
Natural resveratrol analogs differentially target endometriotic cells into apoptosis pathways
Extracellular matrix marker LAMC2 targets ZEB1 to promote TNBC malignancy via up-regulating CD44/STAT3 signaling pathway
Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer
Heparin-binding growth factor (HDGF) drives radioresistance in breast cancer by activating the STAT3 signaling pathway